I like the fact that these studies will be conducted in the USA, Australia and Sth Korea in early as well as late stage cancers. Cellularity have genetically modified NK cells targeting HER2+ gastric cancer. They did seem to hint something going on there as well.
Ann: Imugene HER-Vaxx Phase 2 PFS Data and Flags Three New Trials, page-120
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.0¢ |
Change
-0.002(2.46%) |
Mkt cap ! $439.1M | |||
| Open | High | Low | Value | Volume |
| 6.2¢ | 6.4¢ | 5.9¢ | $607.4K | 10.01M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 28 | 735356 | 5.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.0¢ | 605515 | 16 |
View Market Depth
| Last trade - 14.03pm 06/06/2024 (20 minute delay) ? |
|
|||||
|
Last
6.0¢ |
Change
-0.002 ( 2.91 %) |
||||
| Open | High | Low | Volume | ||
| 6.2¢ | 6.4¢ | 5.9¢ | 3806029 | ||
| Last updated 14.20pm 06/06/2024 ? | |||||
| IMU (ASX) Chart |